Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 298

1.

A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer.

Lydiatt WM, Denman D, McNeilly DP, Puumula SE, Burke WJ.

Arch Otolaryngol Head Neck Surg. 2008 May;134(5):528-35. doi: 10.1001/archotol.134.5.528.

PMID:
18490576
2.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
3.

Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial.

Lydiatt WM, Bessette D, Schmid KK, Sayles H, Burke WJ.

JAMA Otolaryngol Head Neck Surg. 2013 Jul;139(7):678-86. doi: 10.1001/jamaoto.2013.3371.

PMID:
23788218
4.
5.

Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.

Zisook S, Kasckow JW, Lanouette NM, Golshan S, Fellows I, Vahia I, Mohamed S, Rao S.

J Clin Psychiatry. 2010 Jul;71(7):915-22. doi: 10.4088/JCP.09m05699gre.

PMID:
20361918
6.

A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.

Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.

J Clin Psychiatry. 2010 Sep;71(9):1125-30. doi: 10.4088/JCP.09m05086blu.

PMID:
20441723
7.

A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.

Brown ES, Vigil L, Khan DA, Liggin JD, Carmody TJ, Rush AJ.

Biol Psychiatry. 2005 Dec 1;58(11):865-70.

PMID:
15993860
8.

First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.

Habra ME, Baker B, Frasure-Smith N, Swenson JR, Koszycki D, Butler G, van Zyl LT, Lespérance F.

J Psychosom Res. 2010 Aug;69(2):133-41. doi: 10.1016/j.jpsychores.2010.02.010.

PMID:
20624511
9.

An open-label trial of citalopram for major depression in patients with hepatitis C.

Gleason OC, Yates WR, Isbell MD, Philipsen MA.

J Clin Psychiatry. 2002 Mar;63(3):194-8.

PMID:
11926717
10.

Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial.

Lazure KE, Lydiatt WM, Denman D, Burke WJ.

Head Neck. 2009 Jul;31(7):888-92. doi: 10.1002/hed.21046.

PMID:
19309726
11.

Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.

Amsterdam JD, Shults J, Rutherford N.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):100-6.

PMID:
17804135
12.

An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients.

Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD.

Palliat Support Care. 2003 Mar;1(1):71-7.

PMID:
16594290
13.

Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.

Schaefer M, Sarkar R, Knop V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Fromm G, Lieb K, Baumert TF, Heinz A, Discher T, Neumann K, Zeuzem S, Berg T.

Ann Intern Med. 2012 Jul 17;157(2):94-103. doi: 10.7326/0003-4819-157-2-201207170-00006.

PMID:
22801672
14.

Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.

Shoval G, Nahshoni E, Gothelf D, Manor I, Golobchik P, Zemishlany Z, Weizman A, Zalsman G.

Clin Neuropharmacol. 2011 Sep-Oct;34(5):182-5. doi: 10.1097/WNF.0b013e31822cb863.

PMID:
21926484
16.

A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hultén A.

J Clin Psychopharmacol. 2006 Jun;26(3):311-5.

PMID:
16702897
17.
18.

Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus.

Amsterdam JD, Shults J, Rutherford N, Schwartz S.

Neuropsychobiology. 2006;54(4):208-14.

PMID:
17337914
19.

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy.

Klysner R, Bent-Hansen J, Hansen HL, Lunde M, Pleidrup E, Poulsen DL, Andersen M, Petersen HE.

Br J Psychiatry. 2002 Jul;181:29-35.

20.
Items per page

Supplemental Content

Support Center